Obesity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Overweight adolescents; of both sexes; aged between 10 and 17 years; stable weight over a period greater than or equal to 2 months; height greater than 1.45 m, depending on the height of the bicycle seat; not using anorectic drugs or others that could interfere with weight control and controlled hyperinsulinemia and hypothyroidism; be regularly enrolled in school; present the Free and Informed Consent Form signed by the parents or guardians
Exclusion criteria
Exclusion criteria: Present musculoskeletal problems or physical disability that would make it impossible to participate in physical activities; not participating in the second physical evaluation of the project
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1 - Reduction of body fat, determined through bioelectrical impedance, from the observation of a variation of at least 2% in the pre and post-intervention measurements;Observed outcome 1 - (AC300): Reductions in weight, body mass index (BMI) and BMI-score Z, waist circumference (WC) and body fat percentage (%BF) and height increase in both sexes, there were no significant changes in fat-free mass in any groups. (HIIT): Reduction of BMI, BMI-z, AC, waist-to-height ratio (WHtR) and %BF.;Expected outcome 2 - Increase in the level of components of cardiorespiratory fitness measured through the maximum effort test and the 20 meter shutlle run test, based on the observation of a variation of at least 2% in the pre and post-intervention measurements;Observed outcome 2 - (AC300): The resting and maximum heart rates decreased, the workload and the maximum oxygen consumption (VO2max) in ml/kg.min, l/min and ml/kgMLG.min increased in both sexes. (HIIT): decrease in resting heart rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 1 - Improvement of the cardiometabolic profile, assessed by means of the lipid profile, blood glucose, Insulinemia, Blood Pressure, from the finding of a variation of at least 2% in the pre and post-intervention measurements;Observed outcome 1 - (AC300) Reduction of systolic and diastolic blood pressure levels, increased HDL levels and decreased triglycerides, glycemia and insulinemia 120 min. (HIIT):Increased LDL-c and reduced total cholesterol and diastolic blood pressure | — |
Countries
Brazil
Contacts
Universidade Federal do Paraná